Do we need screening for microalbuminuria in Type 2 diabetes?

被引：0
|
作者：
Seereiner, S
Rakovac, I
Habacher, W
Beck, P
Gfrerer, R
Pieber, TR
机构：
[1] Graz Univ, Dept Internal Med, Graz, Austria
[2] Joanneum Res, Graz, Austria
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
955
引用
收藏
页码：A309 / A309
页数：1
相关论文
共 50 条
  • [11] Personalized approach for type 2 diabetes pharmacotherapy: where are we and where do we need to be?
    Abdul-Ghani, Muhammad
    DeFronzo, Ralph A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (16) : 2113 - 2125
  • [12] Screening for microalbuminuria in type I diabetes
    Narchi, H
    JOURNAL OF PEDIATRICS, 2000, 136 (02): : 271 - 271
  • [13] Do we need new drugs for the treatment of type2 diabetes mellitus?
    Vervoort, G.
    Tack, C. J.
    NETHERLANDS JOURNAL OF MEDICINE, 2007, 65 (05): : 157 - 159
  • [14] Comment and response to: dapagliflozin - do we need it registered for type 2 diabetes? response
    Doggrell, Sheila
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (18) : 2752 - 2753
  • [15] Screening for microalbuminuria in type I diabetes - Reply
    Daneman, D
    Sochett, E
    Gorman, D
    JOURNAL OF PEDIATRICS, 2000, 136 (02): : 272 - 272
  • [16] DO WE NEED A CHOLESTEROL SCREENING
    MUNDLOS, S
    EUROPEAN JOURNAL OF PEDIATRICS, 1992, 151 (05) : 392 - 392
  • [17] Screening for microalbuminuria in patients with type 2 diabetes is incomplete in general practice
    Knudsen, Soren Tang
    Mosbech, Thomas Hammershaimb
    Hansen, Birtha
    Konig, Else
    Johnsen, Peter Christian
    Kamper, Anne-Lise
    DANISH MEDICAL JOURNAL, 2012, 59 (09):
  • [18] When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?
    Ustay, Ozlem
    Apaydin, Tugce
    Elbasan, Onur
    Polat, Hamza
    Gunhan, Gizem
    Dincer, Ceyda
    Seker, Lamia
    Ates, Esra Arslan
    Yabaci, Aysegul
    Guney, Ahmet Ilter
    Yavuz, Dilek Gogas
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (01): : 32 - 39
  • [19] Macrovascular disease in type 2 diabetes:: We do need animal models for in vivo studies
    Nitenberg, Alain
    CARDIOVASCULAR RESEARCH, 2007, 73 (03) : 450 - 452
  • [20] Protein ‘pre-loads’ in type 2 diabetes: what do we know and what do we need to find out?
    Christopher K. Rayner
    Jing Ma
    Karen L. Jones
    Peter M. Clifton
    Michael Horowitz
    Diabetologia, 2014, 57 : 2603 - 2604
12345